Wright, J. Fraser
Stanford Medicine · Stanford University
28 papers on CoChatORCID 0000-0001-9635-1750
Most cited papers
- Verified
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 3,509
- Verified
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 2,145
- Verified
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet
Retinal Development and DisordersVirus-based gene therapy research
Cited by 1,952
- Verified
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet
Retinal Development and DisordersVirus-based gene therapy research
Cited by 865
- Verified
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
George, L. A., Sullivan, S. K., Giermasz, A., Rasko, J. E. J., Samelson-Jones, B. J., Ducore, J., Cuker, A., Sullivan, L. M., Majumdar, S., Teitel, J., et al. (2017) · New England Journal of Medicine
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 762
- Verified
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial
Bennett, J., Wellman, J., Marshall, K. A., McCague, S., Ashtari, M., DiStefano-Pappas, J., Elci, O. U., Chung, D. C., Sun, J., Wright, J. F., et al. (2016) · The Lancet
Retinal Development and DisordersVirus-based gene therapy research
Cited by 461
- Verified
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy
Maguire, A. M., Russell, S., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., Marshall, K. A., et al. (2019) · Ophthalmology
Retinal Development and DisordersVirus-based gene therapy research
Cited by 409
- Verified
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Bennett, J., Ashtari, M., Wellman, J., Marshall, K. A., Cyckowski, L. L., Chung, D. C., McCague, S., Pierce, E. A., Chen, Y., Bennicelli, J. L., et al. (2012) · Science Translational Medicine
Retinal Development and DisordersVirus-based gene therapy research
Cited by 395
- Verified
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
Mingozzi, F., Anguela, X. M., Pavani, G., Chen, Y., Davidson, R. J., Hui, D. J., Yazicioglu, M., Elkouby, L., Hinderer, C. J., Faella, A., et al. (2013) · Science Translational Medicine
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 355
- Verified
Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery
Cukras, C., Wiley, H. E., Jeffrey, B. G., Sen, H. N., Turriff, A., Zeng, Y., Vijayasarathy, C., Marangoni, D., Ziccardi, L., Kjellstrom, S., et al. (2018) · Molecular Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 268
- Verified · note
Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene Transfer
Bennicelli, J., Wright, J. F., Komaromy, A., Jacobs, J. B., Hauck, B., Zelenaia, O., Mingozzi, F., Hui, D., Chung, D., Rex, T. S., et al. (2008) · Molecular Therapy
Retinal Development and DisordersVirus-based gene therapy research
Cited by 267
- Verified
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Mingozzi, F., Hasbrouck, N. C., Basner-Tschakarjan, E., Edmonson, S. A., Hui, D. J., Sabatino, D. E., Zhou, S., Wright, J. F., Jiang, H., Pierce, G. F., et al. (2007) · Blood
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 254
- Verified
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
Sommer, J. Ü. M., Smith, P. H., Parthasarathy, S., Isaacs, J., Vijay, S., Kieran, J., Powell, S. K., McClelland, A., & Wright, J. F. (2003) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 230
- Verified
Product-related impurities in clinical-grade recombinant AAV vectors: characterization and risk assessment
Wright, J. (2014) · Biomedicines
Virus-based gene therapy researchProtein purification and stability
Cited by 219
- Verified
Manufacturing and characterizing AAV-based vectors for use in clinical studies
Wright, J. F. (2008) · Gene Therapy
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 205
- Verified
Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation
Wright, J. F., Le, T., Prado, J., Bahr-Davidson, J., Smith, P. H., Zhen, Z., Sommer, J. M., Pierce, G. F., & Qu, G. (2005) · Molecular Therapy
Virus-based gene therapy researchProtein purification and stability
Cited by 158
- Verified
Transient transfection methods for clinical adeno-associated viral vector production
Wright, J. F. (2009) · Human Gene Therapy
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 131
- Verified
Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material
Lock, M., McGorray, S., Auricchio, A., Ayuso, E., Beecham, E. J., Blouin-Tavel, V., Bosch, F., Bose, M., Byrne, B. J., Caton, T., et al. (2010) · Human Gene Therapy
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 131
- Verified
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial
Priddy, F. H., Lewis, D. J. M., Gelderblom, H. C., Hassanin, H., Streatfield, C., LaBranche, C., Hare, J., Cox, J. H., Dally, L., Bendel, D., et al. (2019) · The Lancet HIV
Virus-based gene therapy researchHIV Research and Treatment
Cited by 131
- Verified
Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia b
Mingozzi, F., Chen, Y., Murphy, S. L., Edmonson, S. C., Tai, A., Price, S. D., Metzger, M. E., Zhou, S., Wright, J. F., Donahue, R. E., et al. (2012) · Molecular Therapy
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 112
- Verified
Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses
Ciesielska, A., Hadaczek, P., Mittermeyer, G., Zhou, S., Wright, J. F., Bankiewicz, K. S., & Forsayeth, J. (2013) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 108
- Verified
Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods
Fagone, P., Wright, J. F., Nathwani, A. C., Nienhuis, A. W., Davidoff, A. M., & Gray, J. T. (2012) · Human Gene Therapy Methods
Virus-based gene therapy researchMolecular Biology Techniques and Applications
Cited by 97
- Verified
Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material
Ayuso, E., Blouin, V., Lock, M., McGorray, S., Leon, X., Alvira, M. R., Auricchio, A., Bucher, S., Chtarto, A., Clark, K. R., et al. (2014) · Human Gene Therapy
Virus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Cited by 94
- Verified
Undetectable transcription of cap in a clinical AAV vector: implications for preformed capsid in immune responses
Hauck, B., Murphy, S. L., Smith, P. H., Qu, G., Liu, X., Zelenaia, O., Mingozzi, F., Sommer, J. M., High, K. A., & Wright, J. F. (2009) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 88
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free